I am...
- All
- ECD
- HLH/FEL/FHL
- JXG
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Defining the pathophysiology of HLH in Hematologic Malignancies
Principal Investigator: Dr. Michael Jordan Cincinnati Children’s Hospital Medical Center Cincinatti, OH Date of Award: December 2022 Amount…
Defining and Testing the Hyperinflammatory Immune Synapse
Principal Investigator: Dr. Scott Canna Children’s Hospital of Philadelphia Philadelphia, PA Date of Award: December 2022 Amount…
Immunoproteasome inhibition as a novel therapy for hemophagocytic lymphohistiocytosis (HLH)
Principal Invesigator: Dr. Kim Nichols St. Jude Children’s Research Hospital Memphis, TN Date of Award: December 2022…
A Study of the Spectrum of Visual Function and Choroidal Structure in Patients with Histiocytosis
Principal Investigator: Dr. Jasmine Francis Memorial Sloan Kettering Cancer Center New York City, NY USA Date…
Modeling Langerhans cell Histiocytosis with patient-derived iPSCs
Principal Investigator Dr. Giulio Abagnale St.Anna Children’s Cancer Research Institute Vienna, Austria Date of Award December 2021…
Role of the immune checkpoint TIM-3 in the pathogenesis of non-classical HLH
Principal Investigator Dr. Fernando Sepulveda Imagine Institute Paris, FR Date of Award December 2021 Amount of Award…
Identifying novel CSF Biomarkers for the Diagnosis of Isolated CNS Hemophagocytic Lymphohistiocytosis
Principal Investigator Dr. Sharat Chandra Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio USA Date of Award December…
2020 Grant Cycle
Due to COVID-19 slowing down research and hindering access to laboratories in the Spring of 2020, the…
Excessive IL-10 Potentiates IL-18 to Cooperatively Drive Severe Secondary HLH/MAS-like Disease and Hyper-inflammaphagocytic Macrophage Polarization in Mouse Models.
Gang Huang Cincinnati Children’s Hospital Medical Center, Cincinnati, OH USA
Transcriptional dysregulation of myeloid cells with MAP kinase pathway mutations
Matthew Collin Newcastle University, Newcastle upon Tyne, UK